NEUARTIGE FAP-INHIBITOREN

European patent · EP2804859 · In force

Register entry

Publication number
EP2804859
Application number
EP13701410
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 17, 2013
Published
Nov 26, 2014
Granted
Jun 12, 2019
Protection ends at the latest
Jan 16, 2033
Next annual fee due
Jan 31, 2027
IPC classes
C07D 401/12 (2006.01)
C07D 403/12 (2006.01)
C07D 413/12 (2006.01)
C07D 417/12 (2006.01)
C07D 471/04 (2006.01)
A61K 31/401 (2006.01)
A61P 35/00 (2006.01)
Priority
GB 201200705 17.01.2012
GB 201220458 14.11.2012
PCT application
PCT/EP2013/050845 17.01.2013
PCT publication
WO2013/107820 25.07.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Jun 21, 2022

    Transferred

    Owner
    Universiteit Antwerpen, Prinsstraat 13, 2000 Antwerpen, Belgium, FOX CHASE CANCER CENTER, 333 Cottman Avenue, Philadelphia, PA 19111, USA → Universiteit Antwerpen, Prinsstraat 13, 2000 Antwerpen, Belgium, The Institute for Cancer Research, 333 Cottman Avenue, Philadelphia PA 19111, USA

    Published in Swissreg on 21.06.2022

  6. Jun 12, 2019

    Granted

    Published in Swissreg on 12.06.2019

Parties

Holder

Universiteit Antwerpen

Prinsstraat 13, 2000 Antwerpen, BE

The Institute for Cancer Research

333 Cottman Avenue, Philadelphia PA 19111, US

Inventor

HEIRBAUT, Leen

2610 Wilrijk, BE

CHENG, Jonathan D

Philadelphia, Pennsylvania 19111, US

JOOSSENS, Jurgen

2980 Zoersel, BE

JANSEN, Koen

2610 Wilrijk, BE

DE MEESTER, Ingrid

2610 Wilrijk, BE

VAN DER VEKEN, Pieter

2560 Sint-Katelijne Waver, BE

AUGUSTYNS, Koen

2610 Wilrijk, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.